With the sudden and dramatic impact of COVID-19, a survey of GPs and their contact with pharmaceutical field staff during the pandemic reveals a massive drop in face-to-face engagement. The joint Australian Doctor Group and Medicines Australia poll was sent out in mid-May and attracted almost 400 responders. It shows prior to the pandemic half
As Australia enters a new phase of its COVID-19 journey, governments have an increasing opportunity to engage in a two-way conversation with GPs; not only about the virus itself but also about ensuring their patients don’t ignore their general health during the pandemic. GPs are generally satisfied with the COVID-19 information they have received up to now, according to a survey of AusDoc.PLUS readers1. But a big gripe is that different information sources
To download a PDF version of this infographic, please click here.
During COVID-19, pharma's role extended far beyond new treatments. How the industry's broader support for Australian GPs reshaped trust and transformed HCP engagement models.
COVID-19 accelerated telehealth adoption across Australian general practice almost overnight. Explore what this shift means for pharma engagement and digital HCP marketing strategy.
How Australian Doctor Group responded to COVID-19 — keeping GPs and the healthcare community informed through Australia's #1 independent medical platform during the pandemic.
ADG retains #1 in GP digital and print reach with 48.4% of Australian GPs visiting AusDoc monthly — essential proof-point data for pharma media planning and HCP campaigns.
The 15th PRIME Awards celebrated excellence in Australian healthcare communications. See the complete winners list from pharma, media and health agencies at Sydney's Four Seasons Hotel.
Australian Doctor Group, the country’s number one healthcare media company, is moving its monthly masthead Medical Observer to digital-only next month to meet growing online demand. The important milestone comes after rapid growth in popularity of the masthead’s digital offering following the launch of ADG’s new supersite AusDoc.PLUS five months ago. Since April, the number of doctors
Great pharma content marketing starts with great journalism. 10 reasons why working with editorial professionals produces HCP content that builds trust and drives doctor engagement.
A healthy pipeline feeds a changing treatment landscape A record number of oncology drugs was launched in 2018 with a global report recording 15 new cancer drugs for 17 indications last year. In fact, over the past five years oncology treatments appear to have taken centre stage for the pharmaceutical industry. Some 57 oncology therapies for 89
Leading healthcare media company Australian Doctor Group (ADG) announced today that its new digital sales channel, AccessPlus has “exceeded expectations” with 12 brands signed-on to the platform across a range of therapeutic areas, including respiratory, diabetes, weight loss, dermatology, smoking cessation, female sexual health, mental health, and oncology. Launched late last year, AccessPlus is a